Hypermarcas (OTCMKTS:HYPMY) Shares Cross Below Fifty Day Moving Average - Should You Sell?

Key Points

• Hypermarcas shares fell below their 50-day moving average of $4.46, trading as low as $4.30 during recent market activity.
• Analysts have given Hypermarcas a strong-buy rating, indicating positive sentiment towards the company's stock performance.
• The company announced a dividend of $0.0345 per share, which is set to yield 281.0% for shareholders of record by the ex-dividend date.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $4.46 and traded as low as $4.30. Hypermarcas shares last traded at $4.64, with a volume of 2,195 shares traded.

Wall Street Analysts Forecast Growth

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company presently has an average rating of "Strong Buy".

Hypermarcas Price Performance

The company has a market capitalization of $2.87 billion, a P/E ratio of 21.55 and a beta of 0.86. The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63. The company has a 50 day moving average price of $4.45 and a 200 day moving average price of $4.20.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. This represents a dividend yield of 281.0%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's dividend payout ratio is presently 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.